Cargando…
P889: WILL OUTCOME IMPROVE BY TREATING MULTIPLE MYELOMA PATIENTS AT MRD RELAPSE? THE REMNANT STUDY (RELAPSE FROM MRD NEGATIVITY AS INDICATION FOR TREATMENT)
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430093/ http://dx.doi.org/10.1097/01.HS9.0000846432.28047.c0 |
| _version_ | 1784779654374096896 |
|---|---|
| author | Askeland, F. B. Rasmussen, A.-M. Lysen, A. Haukås, E. Eilertsen, A. Moksnes, M. Tsykunova, G. Vik, A. Eiken, B. D. Sørbø, J. H. Rolke, J. Sand, K. O. Hallstensen, R. F. Myrseth, L. Slørdahl, T. S. Schjesvold, F. |
| author_facet | Askeland, F. B. Rasmussen, A.-M. Lysen, A. Haukås, E. Eilertsen, A. Moksnes, M. Tsykunova, G. Vik, A. Eiken, B. D. Sørbø, J. H. Rolke, J. Sand, K. O. Hallstensen, R. F. Myrseth, L. Slørdahl, T. S. Schjesvold, F. |
| author_sort | Askeland, F. B. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430093 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94300932022-08-31 P889: WILL OUTCOME IMPROVE BY TREATING MULTIPLE MYELOMA PATIENTS AT MRD RELAPSE? THE REMNANT STUDY (RELAPSE FROM MRD NEGATIVITY AS INDICATION FOR TREATMENT) Askeland, F. B. Rasmussen, A.-M. Lysen, A. Haukås, E. Eilertsen, A. Moksnes, M. Tsykunova, G. Vik, A. Eiken, B. D. Sørbø, J. H. Rolke, J. Sand, K. O. Hallstensen, R. F. Myrseth, L. Slørdahl, T. S. Schjesvold, F. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430093/ http://dx.doi.org/10.1097/01.HS9.0000846432.28047.c0 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Askeland, F. B. Rasmussen, A.-M. Lysen, A. Haukås, E. Eilertsen, A. Moksnes, M. Tsykunova, G. Vik, A. Eiken, B. D. Sørbø, J. H. Rolke, J. Sand, K. O. Hallstensen, R. F. Myrseth, L. Slørdahl, T. S. Schjesvold, F. P889: WILL OUTCOME IMPROVE BY TREATING MULTIPLE MYELOMA PATIENTS AT MRD RELAPSE? THE REMNANT STUDY (RELAPSE FROM MRD NEGATIVITY AS INDICATION FOR TREATMENT) |
| title | P889: WILL OUTCOME IMPROVE BY TREATING MULTIPLE MYELOMA PATIENTS AT MRD RELAPSE? THE REMNANT STUDY (RELAPSE FROM MRD NEGATIVITY AS INDICATION FOR TREATMENT) |
| title_full | P889: WILL OUTCOME IMPROVE BY TREATING MULTIPLE MYELOMA PATIENTS AT MRD RELAPSE? THE REMNANT STUDY (RELAPSE FROM MRD NEGATIVITY AS INDICATION FOR TREATMENT) |
| title_fullStr | P889: WILL OUTCOME IMPROVE BY TREATING MULTIPLE MYELOMA PATIENTS AT MRD RELAPSE? THE REMNANT STUDY (RELAPSE FROM MRD NEGATIVITY AS INDICATION FOR TREATMENT) |
| title_full_unstemmed | P889: WILL OUTCOME IMPROVE BY TREATING MULTIPLE MYELOMA PATIENTS AT MRD RELAPSE? THE REMNANT STUDY (RELAPSE FROM MRD NEGATIVITY AS INDICATION FOR TREATMENT) |
| title_short | P889: WILL OUTCOME IMPROVE BY TREATING MULTIPLE MYELOMA PATIENTS AT MRD RELAPSE? THE REMNANT STUDY (RELAPSE FROM MRD NEGATIVITY AS INDICATION FOR TREATMENT) |
| title_sort | p889: will outcome improve by treating multiple myeloma patients at mrd relapse? the remnant study (relapse from mrd negativity as indication for treatment) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430093/ http://dx.doi.org/10.1097/01.HS9.0000846432.28047.c0 |
| work_keys_str_mv | AT askelandfb p889willoutcomeimprovebytreatingmultiplemyelomapatientsatmrdrelapsetheremnantstudyrelapsefrommrdnegativityasindicationfortreatment AT rasmussenam p889willoutcomeimprovebytreatingmultiplemyelomapatientsatmrdrelapsetheremnantstudyrelapsefrommrdnegativityasindicationfortreatment AT lysena p889willoutcomeimprovebytreatingmultiplemyelomapatientsatmrdrelapsetheremnantstudyrelapsefrommrdnegativityasindicationfortreatment AT haukase p889willoutcomeimprovebytreatingmultiplemyelomapatientsatmrdrelapsetheremnantstudyrelapsefrommrdnegativityasindicationfortreatment AT eilertsena p889willoutcomeimprovebytreatingmultiplemyelomapatientsatmrdrelapsetheremnantstudyrelapsefrommrdnegativityasindicationfortreatment AT moksnesm p889willoutcomeimprovebytreatingmultiplemyelomapatientsatmrdrelapsetheremnantstudyrelapsefrommrdnegativityasindicationfortreatment AT tsykunovag p889willoutcomeimprovebytreatingmultiplemyelomapatientsatmrdrelapsetheremnantstudyrelapsefrommrdnegativityasindicationfortreatment AT vika p889willoutcomeimprovebytreatingmultiplemyelomapatientsatmrdrelapsetheremnantstudyrelapsefrommrdnegativityasindicationfortreatment AT eikenbd p889willoutcomeimprovebytreatingmultiplemyelomapatientsatmrdrelapsetheremnantstudyrelapsefrommrdnegativityasindicationfortreatment AT sørbøjh p889willoutcomeimprovebytreatingmultiplemyelomapatientsatmrdrelapsetheremnantstudyrelapsefrommrdnegativityasindicationfortreatment AT rolkej p889willoutcomeimprovebytreatingmultiplemyelomapatientsatmrdrelapsetheremnantstudyrelapsefrommrdnegativityasindicationfortreatment AT sandko p889willoutcomeimprovebytreatingmultiplemyelomapatientsatmrdrelapsetheremnantstudyrelapsefrommrdnegativityasindicationfortreatment AT hallstensenrf p889willoutcomeimprovebytreatingmultiplemyelomapatientsatmrdrelapsetheremnantstudyrelapsefrommrdnegativityasindicationfortreatment AT myrsethl p889willoutcomeimprovebytreatingmultiplemyelomapatientsatmrdrelapsetheremnantstudyrelapsefrommrdnegativityasindicationfortreatment AT slørdahlts p889willoutcomeimprovebytreatingmultiplemyelomapatientsatmrdrelapsetheremnantstudyrelapsefrommrdnegativityasindicationfortreatment AT schjesvoldf p889willoutcomeimprovebytreatingmultiplemyelomapatientsatmrdrelapsetheremnantstudyrelapsefrommrdnegativityasindicationfortreatment |